Could an immune booster help kids fight deadly brain cancer?
NCT ID NCT02359565
First seen Jun 27, 2026 · Last updated Jul 21, 2026 · Updated 2 times
Summary
This early-stage trial is testing the safety and potential benefit of pembrolizumab, an immunotherapy drug, in 71 children whose brain tumors (like DIPG, high-grade gliomas, or medulloblastoma) have come back or not responded to standard treatments. The drug works by helping the body's immune system attack cancer cells. The main goals are to find the best dose and see if it can shrink tumors or slow their growth.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CONSTITUTIONAL MISMATCH REPAIR DEFICIENCY SYNDROME are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Children's Healthcare of Atlanta - Arthur M Blank Hospital
Atlanta, Georgia, 30329, United States
-
Children's Hospital Colorado
Aurora, Colorado, 80045, United States
-
Children's Hospital Los Angeles
Los Angeles, California, 90027, United States
-
Children's Hospital of Pittsburgh of UPMC
Pittsburgh, Pennsylvania, 15224, United States
-
Children's National Medical Center
Washington D.C., District of Columbia, 20010, United States
-
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, 45229, United States
-
Hospital for Sick Children
Toronto, Ontario, M5G 1X8, Canada
-
Lucile Packard Children's Hospital Stanford University
Palo Alto, California, 94304, United States
-
Lurie Children's Hospital-Chicago
Chicago, Illinois, 60611, United States
-
Memorial Sloan Kettering Cancer Center
New York, New York, 10065, United States
-
Saint Jude Children's Research Hospital
Memphis, Tennessee, 38105, United States
-
Texas Children's Hospital
Houston, Texas, 77030, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a walking routine alter cancer biomarkers? new trial investigates
- Targeted radiation zaps childhood brain tumors in early trial
- Digital assistant aims to close gaps in hereditary cancer care
- Spinal fluid DNA test could personalize brain cancer therapy
- Targeted drug aims to shrink recurrent brain tumors by blocking key growth enzyme
- Parental distress may undermine treatment in children with recurrent brain tumors